Mummaneni Padmaja is categorized under Noncommercial Biological Research Organization in Bethesda, MD and active since 2004.
Mummaneni Padmaja was established in 2004, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Noncommercial Biological Research Organization business, which does work in the B2B market, and is classified as a Noncommercial Biological Research Organization, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Padmaja Mummaneni at the company’s single location by writing to 10513 Montrose Avenue, Bethesda, Maryland MD 20814 or by phoning (301) 493-9664. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mummaneni Padmaja |
| Contact Person: | Padmaja Mummaneni |
| Address: | 10513 Montrose Avenue, Bethesda, Maryland 20814 |
| Phone Number: | (301) 493-9664 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biological Research Organization |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Mummaneni Padmaja was started in 2004 to provide professional Noncommercial Biological Research Organization under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Padmaja Mummaneni for inquiries that concern Mummaneni Padmaja by calling the company number (301) 493-9664, as your correspondence is most welcome. Additionally, the physical location of the single location of Mummaneni Padmaja can be found at the coordinates 39.028335,-77.096766 as well as the street address 10513 Montrose Avenue in Bethesda, Maryland 20814.
For its online presence, you may visit Mummaneni Padmaja’s website at and engage with its social media outlets through on Twitter and on Facebook.